TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998
TCL Archive FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency August 14, 1992
TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004